Daily BriefsMost Read

Most Read: KDDI Corp, Nissin Corp, JD.com , Yichang HEC Changjiang Pharma, Greatview Aseptic Packaging, Great Eastern Holdings, Sumitomo Chemical, Naver Corp, LG Chem and more

In today’s briefing:

  • KDDI (9433) – Own Share Tender Offer, Toyota To Sell (Gasp!) Redux (Another Buyback in H2 Possible)
  • Nissin (9066) – Super Big Buyback Race-Walks the Governance Walk – Super Cheap Logistics Biz
  • Great Eastern (GE SP): OCBC’s S$25.60 Unconditional Offer
  • HSTECH Index Rebalance Preview: Round-Trip Trade of US$2.4bn in June
  • HEC CJ Pharma (1558 HK): Pre-Conditional Share Exchange Offer from Largest Shareholder
  • Greatview Aseptic (468 HK): Shandong Xinjufeng VGO Could Force Mengniu to Act
  • Great Eastern Holdings (GE SP): OCBC’s Offer Needs a Bump to Achieve Privatisation Ambitions
  • Sumitomo Chemical (4005): To Believe Or Not To Believe, That Is the Question
  • Local Reports in Korea Regarding A Holdings Stake Sale Between Naver & Softbank
  • Underexposed Flow Trading Opportunity: LONG Banks & SHORT LG Chem/Energy on June 14


KDDI (9433) – Own Share Tender Offer, Toyota To Sell (Gasp!) Redux (Another Buyback in H2 Possible)

By Travis Lundy

  • In May 2023, KDDI Corp (9433 JP) announced a ¥300bn buyback program, did nothing for two months, then announced a Tender Offer Buyback to buy shares from Toyota. 
  • Toyota had increased its stake years before, then KDDI bought back shares from others, so Toyota was backing its ownership down. I discussed the relationships, history, etc, here.
  • This year, KDDI announced Friday with earnings that is buying back another large stake from Toyota. 

Nissin (9066) – Super Big Buyback Race-Walks the Governance Walk – Super Cheap Logistics Biz

By Travis Lundy

  • Yesterday after the close, Nissin Corp (9066 JP) announced earnings (down vs last year), guidance (back up partway to last year), and a sale of securities to raise ¥6+bn.
  • Nissin also announced an employee share incentive plan (¥900mm) and an adjustment to its MTMP from Apr24 to Mar27. Much lower revenues. Same OP. Higher net. Higher Div Payout ratio.
  • They also announced a really big buyback which should be done by the time people read this. It is really big.

Great Eastern (GE SP): OCBC’s S$25.60 Unconditional Offer

By David Blennerhassett


HSTECH Index Rebalance Preview: Round-Trip Trade of US$2.4bn in June

By Brian Freitas


HEC CJ Pharma (1558 HK): Pre-Conditional Share Exchange Offer from Largest Shareholder

By Arun George

  • Yichang HEC Changjiang Pharma (1558 HK)‘s pre-conditional privatisation from Sunshine Lake Pharma comprises scrip (0.263614 new offeror H Share per HEC CJ Pharma share) and cash (special dividend of HK$1.5).
  • The pre-condition is regulatory approvals from NDRC, MOFCOM, and SAFE. The key condition is approval by at least 75% of independent H Shareholders (<10% of all independent H Shareholders rejection). 
  • There is valuation uncertainty as the offeror is unlisted, and its valuation hinges on pipeline products. Nevertheless, with no shareholder close to a blocking stake, the deal should get up.   

Greatview Aseptic (468 HK): Shandong Xinjufeng VGO Could Force Mengniu to Act

By Arun George


Great Eastern Holdings (GE SP): OCBC’s Offer Needs a Bump to Achieve Privatisation Ambitions

By Arun George

  • OCBC (OCBC SP) has announced a voluntary unconditional general offer for Great Eastern Holdings (GE SP) at S$25.60 per share, a 36.90% premium to the undisturbed price.
  • OCBC aims to privatise Great Eastern by delisting resolutions or exercising compulsory acquisition rights. The offer has not been declared final.
  • While the offer is reasonable, it is not a knockout bid which would comfortably allow OCBC to privatise through either option. A bump is highly likely.   

Sumitomo Chemical (4005): To Believe Or Not To Believe, That Is the Question

By Michael Allen

  • Sumitomo Chemical issued new guidance in-line for 3/24 and xx% ahead of consensus for 3/25 EBIT, yet, the shares promptly declined by 10%.
  • Traders were probably spooked by the company’s booking of ¥340bn in impairments that was ¥200bn more than published consensus, but we argue that this was more than already priced in.
  • The only reasonable explanation for the reaction is that the market doesn’t believe the new guidance for 3/25. This could prove to be a huge mistake.

Local Reports in Korea Regarding A Holdings Stake Sale Between Naver & Softbank

By Sanghyun Park

  • Naver doesn’t view the sale of its A Holdings stake unfavorably; insiders suggest it’s been planning this move since last year.
  • Market speculation suggests Naver was disappointed by Softbank’s rejection of CLOVA X in LINE, prompting plans to sell A Holdings stake for AI development. A sale agreement is expected soon.
  • The method through which Softbank secures funds for this acquisition is worth the attention from a short-term trading perspective.

Underexposed Flow Trading Opportunity: LONG Banks & SHORT LG Chem/Energy on June 14

By Sanghyun Park

  • Despite time until screening, predictions likely hold due to market cap gaps; all candidates are banks, benefiting from recent momentum.
  • Historical patterns show profit-taking selling affecting price impact, particularly on additions with significant pre-inclusion price rises. Monitor banks’ pre-June 14th price appreciation to anticipate impact distortions.
  • Shorting LG Chem and LG Energy Solution based on high price cointegration, consider basket-trading them before the rebalancing, using the battery sector as a long hedge.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars